Layn Pharma’s net profit falls by 18.49% in first three quarters of 2019

Summary: Layn Pharma issued the third quarterly results on 30 Oct., which achieved the operating income of USD55.51 million (RMB391 million) in the first three quarters of 2019, down by 14.23% YoY, and the net profit of USD9.01 million (RMB63.45 mill...

Sweeteners China News 201911

www.cnchemicals.com